Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,950,119
-
Total 13F shares
-
230,362
-
Share change
-
+203,855
-
Total reported value
-
$204,170
-
Price per share
-
$0.89
-
Number of holders
-
2
-
Value change
-
+$180,677
-
Number of buys
-
2
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2023
As of 31 Dec 2023,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
230,362 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, ARMISTICE CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, JACOBS LEVY EQUITY MANAGEMENT, INC, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, Assenagon Asset Management S.A., TWO SIGMA INVESTMENTS, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.